Nano-magnolol enhances the modulatory effects of magnolol on cognitive performance and BACE1-related biochemical changes in an STZ-induced rat model of Alzheimer's disease. This evidence concerns the gene BACE1 and early-onset autosomal dominant Alzheimer disease.